- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CURATIVE BIOTECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 11.09. | Curative Biotechnology, Inc.: Curative Biotechnology, Inc. Issues Letter to Shareholders | 410 | GlobeNewswire (Europe) | Company Reviews Significant Ophthalmology, Intellectual Property and Translational Development Milestones Achieved Over the Past Year Palm Beach Gardens, FL, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Curative... ► Artikel lesen | |
| 15.04. | Curative Biotechnology, Inc.: Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply of Metformin Topical Ophthalmic Therapy | 705 | GlobeNewswire (Europe) | Manufacturing Agreement Advances Metformin Ophthalmology Platform Toward First-in-Human Clinical Study Palm Beach Gardens, FL, April 15, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT... ► Artikel lesen | |
| 24.03. | Curative Biotechnology, Inc.: Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting | 614 | GlobeNewswire (Europe) | Strengthening Capital Structure and Advancing Clinical Development Strategy Palm Beach Gardens, FL, March 23, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBTD) ("Curative" or the "Company")... ► Artikel lesen | |
| 23.01. | Curative Biotechnology, Inc.: Curative Biotechnology Announces Canadian Patent Allowance | 614 | GlobeNewswire (Europe) | "Druggable Target to Treat Retinal Degeneration" Palm Beach Gardens, FL, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) ("Curative" or the "Company"), a company developing... ► Artikel lesen | |
| 18.11.25 | Curative Biotechnology, Inc. Announces Letter to Shareholders | 275 | GlobeNewswire (Europe) | Strategic Update and New Path to Value Creation Palm Beach Gardens, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) ("Curative Biotech" or the "Company"), a development-stage... ► Artikel lesen |
5 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 41,020 | -0,27 % | QIAGEN N.V.: QIAGEN Convenes Global Tuberculosis Experts as New Pressures Challenge Progress Against Tuberculosis | Global TB Summit brings together international experts as persistent disease burden and funding pressures challenge progress against tuberculosis QuantiFERON-TB Gold Plus detects tuberculosis... ► Artikel lesen | |
| MODERNA | 189,48 | -10,16 % | 3 Transportvehikel für die Präzisionsmedizin: Warum Moderna, uniQure und NurExone auf Lipide, Viren und Exosomen setzen | ||
| RECURSION PHARMACEUTICALS | 3,745 | -9,98 % | Recursion Pharmaceuticals (RXRX) Stock is Trending After Hours: Here's What You Should Know | ||
| PRAXIS PRECISION MEDICINES | 245,66 | -1,04 % | Praxis Precision Medicines, Inc.: Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies | FDA sets updated PDUFA date of December 27, 2026 BOSTON, June 29, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS)... ► Artikel lesen | |
| NURIX THERAPEUTICS | 24,870 | -0,32 % | Nurix Therapeutics Swings To Profit In Q3 On Roche Licensing Revenue | SOUTH SAN FRANCISCO (dpa-AFX) - Nurix Therapeutics, Inc. (NRIX), clinical-stage biopharmaceutical company, reported a swing to profit in the third quarter from a loss in the year-ago period... ► Artikel lesen | |
| CG ONCOLOGY | 60,11 | 0,00 % | CG Oncology appoints Isabel Kalofonos as chief commercial officer | ||
| TARSUS PHARMACEUTICALS | 68,82 | -2,95 % | Tarsus Pharmaceuticals, Inc: Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care | Adds gildeuretinol (ALK-001), a differentiated Phase 3 oral investigational medicine designed to target the underlying biology of Stargardt's disease, a potentially blinding disease with no FDA-approved... ► Artikel lesen | |
| TANGO THERAPEUTICS | 22,590 | 0,00 % | Tango Therapeutics, Inc.: Tango Therapeutics to Present Updated Vopimetostat + RAS(ON) Combination Data at European Society For Medical Oncology (ESMO) Congress 2026 | ||
| BIONTECH | 78,70 | -2,18 % | Evotec crasht, BioNTech wackelt: Warum die Biotech-Baisse ausgerechnet dieses Nischenfeld verschont | ||
| ERASCA | 13,770 | -7,40 % | Erasca drops after sacking COO | ||
| COGENT BIOSCIENCES | 29,175 | -1,14 % | Cogent Biosciences, Inc.: Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) for Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM) | NDA supported by positive results from the APEX pivotal trial demonstrating clinically meaningful responses and evidence of disease modification in patients with AdvSM PDUFA target action date set... ► Artikel lesen | |
| EVOTEC | 2,570 | +1,66 % | BRANDMELDUNG bei Evotec: Ist das der Beginn einer Kursexplosion? - Handeln Sie noch vor dem Wochenende! | ||
| SUMMIT THERAPEUTICS | 14,880 | -3,19 % | Summit Therapeutics Secures $2B Strategic Investment From AstraZeneca | LONDON (dpa-AFX) - Summit Therapeutics Inc. (SMMT) on Monday announced the closing of AstraZeneca's (AZN) $2 billion strategic equity investment, which will support accelerated development of... ► Artikel lesen | |
| ALAUNOS THERAPEUTICS | 2,370 | +8,72 % | Paragon Labs Adds Former Apogee Leaders As Alaunos Completes Velaris Acquisition; Stock Up | WASHINGTON (dpa-AFX) - Paragon Labs announced that several former senior executives from Apogee Therapeutics (APGE) have joined its leadership team, while Alaunos Therapeutics, Inc. (TCRT) completed... ► Artikel lesen | |
| ARCUTIS BIOTHERAPEUTICS | 28,340 | -2,61 % | Why Is Arcutis Biotherapeutics Stock Surging Thursday? |
CURATIVE BIOTECHNOLOGY INC gehört der Branche Biotechnologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CURATIVE BIOTECHNOLOGY INC finden Sie auf Wallstreet Online.